267 results on '"A. Girnita"'
Search Results
2. Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease
3. Determination of Wheel-Rail Interaction Forces of Railway Vehicles for Evaluation of Safety Against Derailment at Running on Twisted Tracks
4. Competing engagement of β-arrestin isoforms balances IGF1R/p53 signaling and controls melanoma cell chemotherapeutic responsiveness
5. INDIVIDUAL ARTICLE: NECOM 3: A Practical Algorithm for the Management of Radiation Therapy-Related Acute Radiation Dermatitis
6. Blurring Boundaries: Receptor Tyrosine Kinases as functional G Protein-Coupled Receptors
7. Correction: The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway
8. Retraction Note: Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor
9. Correction: Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and β-arrestin1
10. Supplementary table 5 from Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism
11. Supplementary figure 1 from Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism
12. Supplementary table 6 from Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism
13. Supplementary table 2 from Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism
14. Supplementary figure 2 from Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism
15. Supplementary table 1 from Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism
16. Supplementary Materials and Methods and Supplementary Figure and Table Legends from Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism
17. Supplementary table 3 from Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism
18. Supplementary table 4 from Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism
19. Data from Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism
20. Editorial: DNA damage response pathways meet endocrine systems
21. Differential Regulation of IGF-1 and Insulin Signaling by GRKs
22. Chapter Seven - When Phosphorylation Encounters Ubiquitination: A Balanced Perspective on IGF-1R Signaling
23. Editorial Expression of Concern: Gene expression profile by blocking the SYT-SSX fusion gene in synovial sarcoma cells. Identification of XRCC4 as a putative SYT-SSX target gene
24. Association of metformin use and survival in patients with cutaneous melanoma and diabetes
25. Analysis of Cross-sectional and Longitudinal HLA and Anti-viral Responses After COVID Infection in Renal Allograft Recipients: Differences and Correlates
26. Mohs micrographic surgery revisited: A multidisciplinary, collaborative approach for the treatment of aggressive and recurrent basal cell carcinoma on the head and neck
27. IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma
28. Anti-HLA DQ Antibodies Are Associated with Chronic Lung Allograft Dysfunction in a Pediatric Lung Transplant Population
29. 26653 Can β-arrestin isoforms control response of melanoma cells to chemotherapy?
30. It Takes Two to Tango: IGF-I and TSH Receptors in Thyroid Eye Disease
31. Inhibition of G Protein–Coupled Receptor Kinase 2 Promotes Unbiased Downregulation of IGF1 Receptor and Restrains Malignant Cell Growth
32. Delayed Kinetics of IgG, but Not IgA, Antispike Antibodies in Transplant Recipients following SARS-CoV-2 Infection
33. Sjogren’s Syndrome Presenting with Solely Cutaneous Features
34. Corrigendum: Impact of modern systemic therapies and clinical markers on treatment outcome for metastatic melanoma in a real‐world setting
35. Correction: Differences in cutaneous melanoma treatment and patient satisfaction
36. The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling
37. Impact of modern systemic therapies and clinical markers on treatment outcome for metastatic melanoma in a real‐world setting
38. The tale of a tail: The secret behind IGF-1R’s oncogenic power
39. Below the Surface: IGF-1R Therapeutic Targeting and Its Endocytic Journey
40. β-arrestin1 is involved in the Ras-induced malignant transformation
41. IRS-2 deubiquitination by USP9X maintains anchorage-independent cell growth via Erk1/2 activation in prostate carcinoma cell line
42. Proteasomal adaptations underlying carfilzomib-resistance in human bone marrow plasma cells
43. A prospective, iterative, adaptive trial of carfilzomib-based desensitization
44. Reducing Donor-specific Antibody During Acute Rejection Diminishes Long-term Renal Allograft Loss: Comparison of Early and Late Rejection
45. Ten-year Follow-up Study of Grenz Ray Treatment for Lentigo Maligna and Early Lentigo Maligna Melanoma
46. Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic Melanoma
47. Non-Coding RNAs in IGF-1R Signaling Regulation: The Underlying Pathophysiological Link between Diabetes and Cancer
48. Prediction of BAP1 Expression in Uveal Melanoma Using Densely-Connected Deep Classification Networks
49. Editor's Note: Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism
50. OR24 Alloantibody testing in transplantation: To bind or not to bind complement?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.